Individuals with type 2 diabetes often experience impaired insulin secretion in the first phase [107], the study by T. Vilsbøll confirmed that liraglutide increased insulin secretion in both the first phase (approximately 2 min after the rise in blood glucose levels) and the second phase [108]. This evidence concerns the gene INS and type 2 diabetes mellitus.